P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Urethra -ve | Urethra +ve | Total | |||||
P1 | Pharynx -ve | 942 | 22 | 964 | 2.3% (1.4 to 3.4) | Ref | Ref |
Pharynx +ve | 15 | 11 | 26 | 42.3% (23.4 to 63.1) | 31.4*** | 18.3*** | |
Total | 957 | 33 | 990 | 3.3% (2.3 to 4.6) | (13.0 to 76.1) | (6.9 to 48.8) | |
P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Pharynx -ve | Pharynx +ve | Total | |||||
P1 | Pharynx -ve | 944 | 20 | 964 | 2.1% (1.3 to 3.2) | Ref | Ref |
Pharynx +ve | 20 | 6 | 26 | 23.1% (9.0 to 43.6) | 14.2*** | 2.5 | |
Total | 964 | 26 | 990 | 2.6% (1.7 to 3.8) | (5.1 to 39.0) | (0.7 to 8.4) | |
P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Rectum -ve | Rectum +ve | Total | |||||
P1 | Pharynx -ve | 927 | 37 | 964 | 3.8% (2.7 to 5.3) | Ref | Ref |
Pharynx +ve | 15 | 11 | 26 | 42.3% (23.4 to 63.1) | 18.4*** | 8.9*** | |
Total | 942 | 48 | 990 | 4.8% (3.6 to 6.4) | (7.9 to 42.8) | (3.2 to 24.6) |